Clinical trials: Hydroxychloroquine Adverse Reaction
Coronavirus Infection, Hydroxychloroquine Adverse Reaction
Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19
The Coronavirus Disease 2019 (COVID-19) pandemic has placed tremendous stress on the global economy since its outbreak in December 2019.
- Trial name
- SHARP COVID-19 (NCT04342156)
- Testing
- Hydroxychloroquine Sulfate 200 milligram (mg) Tab
- Volunteers
- healthy volunteers welcome
- Sponsor
- Tan Tock Seng Hospital